Peter Maslak, MD
I have a long-standing interest in immunologic approaches to cancer therapeutics and have the laboratory as well as clinical background. I recently have joined Roswell Park Comprehensive Cancer Center, where I am the Vice Chair of Clinical Operations, the Director of Flow Cytometry in the Immune Monitoring Shared Resources and the Technical Director of the Flow Cytometry Lab with Pathology and Laboratory Medicine. Prior to this, I was Chief of the Immunology Service in the Department of Laboratory Medicine and an attending physician on the Leukemia Service in the Department of Medicine at Memorial-Sloan Kettering Cancer Center.
I have more than 25 years of experience in clinical flow cytometry and immunophenotyping and have been instrumental in developing laboratory correlates in support of various clinical trials with a particular emphasis on the therapy of leukemia. I managed the activity of a CLIA deemed laboratory which supported all hematopoietic stem cell and cellular therapy at MSKCC. The laboratory was actively involved in monitoring immune reconstitution as well as defining the graft content in the setting of various ex vivo manipulations performed on both peripheral blood and bone marrow. During the recent COVID pandemic, we played a major role in helping to define the immune response immunocompromised cancer patients.
My current research interests also include identifying immunologic targets and the implementation of strategies such as vaccination and cell based therapies to harness the immune system and effect cure.